Detailed Mechanism Funding and Narrative

Years of mechanism: 2014 2015 2016 2017 2018

Details for Mechanism ID: 17361
Country/Region: Cameroon
Year: 2017
Main Partner: Cameroon Baptist Convention Health Services
Main Partner Program: NA
Organizational Type: FBO
Funding Agency: HHS/CDC
Total Funding: $10,302,471 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Testing: HIV Testing and Counseling (HVCT) $1,072,567
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $1,077,984
Treatment: Adult Treatment (HTXS) $7,733,139
Treatment: Pediatric Treatment (PDTX) $418,781
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
GEND_GBV <10, Female, Physical and/or Emotional Violence 2018 3
GEND_GBV <10, Female, Sexual Violence (Post-Rape Care) 2018 3
GEND_GBV 10-14, Female, Physical and/or Emotional Violence 2018 9
GEND_GBV 10-14, Female, Sexual Violence (Post-Rape Care) 2018 9
GEND_GBV 10-14, Male, Physical and/or Emotional Violence 2018 6
GEND_GBV 15-19, Female, Physical and/or Emotional Violence 2018 6
GEND_GBV 15-19, Female, Sexual Violence (Post-Rape Care) 2018 6
GEND_GBV 15-19, Male, Physical and/or Emotional Violence 2018 3
GEND_GBV 15-19, Male, Sexual Violence (Post-Rape Care) 2018 3
GEND_GBV 20-24, Female, Physical and/or Emotional Violence 2018 8
GEND_GBV 20-24, Female, Sexual Violence (Post-Rape Care) 2018 6
GEND_GBV 25-49, Female, Physical and/or Emotional Violence 2018 52
GEND_GBV 25-49, Female, Sexual Violence (Post-Rape Care) 2018 30
GEND_GBV 25-49, Male, Physical and/or Emotional Violence 2018 3
GEND_GBV 25-49, Male, Sexual Violence (Post-Rape Care) 2018 3
GEND_GBV By PEP service provision (related to sexual violence services provided) 2018 36
GEND_GBV By type of service: Physical and/or Emotional Violence (Other Post-GBV Care) 2018 90
GEND_GBV By type of service: Sexual Violence (Post-Rape Care) 2018 60
GEND_GBV Number of people receiving post-GBV care 2018 150
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2018 225,562
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2018 293,856
HTS_TST Service Delivery Point (Facility) Malnutrition: Negative 2018 3
HTS_TST Service Delivery Point (Facility) Pediatric : <5 Negative 2018 4,092
HTS_TST Service Delivery Point (Facility) Pediatric : <5 Negative 2018 7,358
HTS_TST Service Delivery Point Agg Age (Facility) ANC: 15+, Negative 2018 82,979
HTS_TST Service Delivery Point Agg Age (Facility) Index: <15, Female, Negative 2018 44
HTS_TST Service Delivery Point Agg Age (Facility) Index: <15, Female, Negative 2018 687
HTS_TST Service Delivery Point Agg Age (Facility) Index: <15, Male, Negative 2018 29
HTS_TST Service Delivery Point Agg Age (Facility) Index: <15, Male, Negative 2018 734
HTS_TST Service Delivery Point Agg Age (Facility) Index: 15+, Female, Negative 2018 563
HTS_TST Service Delivery Point Agg Age (Facility) Index: 15+, Male, Negative 2018 105
HTS_TST Service Delivery Point Agg Age (Facility) Index: 15+, Male, Negative 2018 1,888
HTS_TST Service Delivery Point Agg Age (Facility) Inpatient: <15, Female, Negative 2018 474
HTS_TST Service Delivery Point Agg Age (Facility) Inpatient: <15, Male, Negative 2018 712
HTS_TST Service Delivery Point Agg Age (Facility) Inpatient: 15+, Female, Negative 2018 6,269
HTS_TST Service Delivery Point Agg Age (Facility) Inpatient: 15+, Male, Negative 2018 9,398
HTS_TST Service Delivery Point Agg Age (Facility) Other PITC: <15, Female, Negative 2018 2,171
HTS_TST Service Delivery Point Agg Age (Facility) Other PITC: <15, Male, Negative 2018 2,160
HTS_TST Service Delivery Point Agg Age (Facility) Other PITC: 15+, Female, Negative 2018 34,445
HTS_TST Service Delivery Point Agg Age (Facility) Other PITC: 15+, Male, Negative 2018 64,609
HTS_TST Service Delivery Point Agg Age (Facility) TB: 15+, Female, Negative 2018 338
HTS_TST Service Delivery Point Agg Age (Facility) TB: 15+, Male, Negative 2018 1,080
HTS_TST Service Delivery Point by Agg Age (Facility) ANC: 15+, Negative 2018 94,635
HTS_TST Service Delivery Point by Agg Age (Facility) Inpatient: <15, Female, Negative 2018 1,206
HTS_TST Service Delivery Point by Agg Age (Facility) Inpatient: <15, Male, Negative 2018 1,252
HTS_TST Service Delivery Point by Agg Age (Facility) Inpatient: 15+, Female, Negative 2018 2,049
HTS_TST Service Delivery Point by Agg Age (Facility) Inpatient: 15+, Male, Negative 2018 6,942
HTS_TST Service Delivery Point by Agg Age (Facility) Other PITC: <15, Female, Negative 2018 6,033
HTS_TST Service Delivery Point by Agg Age (Facility) Other PITC: <15, Male, Negative 2018 5,198
HTS_TST Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Female, Negative 2018 17,625
HTS_TST Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Male, Negative 2018 54,909
HTS_TST Service Delivery Point by Agg Age (Facility) TB: 15+, Female, Negative 2018 264
HTS_TST Service Delivery Point by Agg Age (Facility) TB: 15+, Male, Negative 2018 957
HTS_TST Sum of Test Result disaggregates 2018 16,595
HTS_TST Sum of Test Result disaggregates 2018 10,828
HTS_TST_POS By Test Result: Positive 2018 16,595
HTS_TST_POS By Test Result: Positive 2018 10,828
HTS_TST_POS Service Delivery Point (Facility) Pediatric : <5 Positive 2018 128
HTS_TST_POS Service Delivery Point (Facility) Pediatric : <5 Positive 2018 161
HTS_TST_POS Service Delivery Point Agg Age (Facility) ANC: 15+, Positive 2018 3,826
HTS_TST_POS Service Delivery Point Agg Age (Facility) Index: <15, Female, Positive 2018 1
HTS_TST_POS Service Delivery Point Agg Age (Facility) Index: <15, Female, Positive 2018 8
HTS_TST_POS Service Delivery Point Agg Age (Facility) Index: <15, Male, Positive 2018 16
HTS_TST_POS Service Delivery Point Agg Age (Facility) Index: 15+, Female, Positive 2018 135
HTS_TST_POS Service Delivery Point Agg Age (Facility) Index: 15+, Male, Positive 2018 26
HTS_TST_POS Service Delivery Point Agg Age (Facility) Index: 15+, Male, Positive 2018 481
HTS_TST_POS Service Delivery Point Agg Age (Facility) Inpatient: <15, Female, Positive 2018 9
HTS_TST_POS Service Delivery Point Agg Age (Facility) Inpatient: <15, Male, Positive 2018 19
HTS_TST_POS Service Delivery Point Agg Age (Facility) Inpatient: 15+, Female, Positive 2018 304
HTS_TST_POS Service Delivery Point Agg Age (Facility) Inpatient: 15+, Male, Positive 2018 536
HTS_TST_POS Service Delivery Point Agg Age (Facility) Other PITC: <15, Female, Positive 2018 31
HTS_TST_POS Service Delivery Point Agg Age (Facility) Other PITC: <15, Male, Positive 2018 36
HTS_TST_POS Service Delivery Point Agg Age (Facility) Other PITC: 15+, Female, Positive 2018 3,695
HTS_TST_POS Service Delivery Point Agg Age (Facility) Other PITC: 15+, Male, Positive 2018 7,491
HTS_TST_POS Service Delivery Point Agg Age (Facility) TB: 15+, Female, Positive 2018 173
HTS_TST_POS Service Delivery Point Agg Age (Facility) TB: 15+, Male, Positive 2018 301
HTS_TST_POS Service Delivery Point by Agg Age (Facility) ANC: 15+, Positive 2018 3,099
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Inpatient: <15, Female, Positive 2018 25
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Inpatient: <15, Male, Positive 2018 30
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Inpatient: 15+, Female, Positive 2018 153
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Inpatient: 15+, Male, Positive 2018 527
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Other PITC: <15, Female, Positive 2018 108
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Other PITC: <15, Male, Positive 2018 108
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Female, Positive 2018 1,372
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Male, Positive 2018 4,163
HTS_TST_POS Service Delivery Point by Agg Age (Facility) TB: 15+, Female, Positive 2018 87
HTS_TST_POS Service Delivery Point by Agg Age (Facility) TB: 15+, Male, Positive 2018 345
PMTCT_ART Already on ART at beginning of current pregnancy 2018 2,135
PMTCT_ART Already on ART at beginning of current pregnancy 2018 2,590
PMTCT_ART New on ART 2018 3,431
PMTCT_ART New on ART 2018 2,715
PMTCT_ART Number of HIV-positive pregnant women who received ART to reduce risk of mother-to-child-transmission (MTCT) during pregnancy 2018 5,566
PMTCT_ART Number of HIV-positive pregnant women who received ART to reduce risk of mother-to-child-transmission (MTCT) during pregnancy 2018 5,305
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2018 88,437
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2018 100,613
PMTCT_EID Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2018 5,020
PMTCT_EID Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2018 5,862
PMTCT_EID Number of infants with a negative virological test result between 2 and 12 months of birth 2018 776
PMTCT_EID Number of infants with a negative virological test result between 2 and 12 months of birth 2018 618
PMTCT_EID Number of infants with a negative virological test result within 2 months of birth 2018 3,637
PMTCT_EID Number of infants with a negative virological test result within 2 months of birth 2018 4,766
PMTCT_EID Number of infants with a positive virological test result between 2 and 12 months of birth 2018 44
PMTCT_EID Number of infants with a positive virological test result between 2 and 12 months of birth 2018 22
PMTCT_EID Number of infants with a positive virological test result within 2 months of birth 2018 101
PMTCT_EID Number of infants with a positive virological test result within 2 months of birth 2018 70
PMTCT_EID Unknown, <= 2 months 2018 327
PMTCT_EID Unknown, <= 2 months 2018 283
PMTCT_EID Unknown, 2 - 12 months 2018 135
PMTCT_EID Unknown, 2 - 12 months 2018 103
PMTCT_STAT By Age (Numerator): : 15-19 2018 6,856
PMTCT_STAT By Age (Numerator): 15-19 2018 4,556
PMTCT_STAT By Age (Numerator): 20-24 2018 10,513
PMTCT_STAT By Age (Numerator): 20-24 2018 15,844
PMTCT_STAT By Age (Numerator): 25-49 2018 19,970
PMTCT_STAT By Age (Numerator): 25-49 2018 30,091
PMTCT_STAT By Age (Numerator): Unknown Age 2018 65,574
PMTCT_STAT By Age (Numerator): Unknown Age 2018 35,646
PMTCT_STAT By known positives: <Unknown Age 2018 761
PMTCT_STAT By known positives: 15-19 2018 179
PMTCT_STAT By known positives: 20-24 2018 419
PMTCT_STAT By known positives: 25-49 2018 779
PMTCT_STAT By new negatives: 15-19 2018 6,342
PMTCT_STAT By new negatives: 20-24 2018 14,648
PMTCT_STAT By new negatives: 25-49 2018 27,819
PMTCT_STAT By new negatives: Unknown Age 2018 33,529
PMTCT_STAT By new positives: 15-19 2018 340
PMTCT_STAT By new positives: 20-24 2018 788
PMTCT_STAT By new positives: 25-49 2018 1,476
PMTCT_STAT By new positives: 50+ 2018 1
PMTCT_STAT By new positives: Unknown Age 2018 1,355
PMTCT_STAT By Number of known positives: 15-19 2018 117
PMTCT_STAT By Number of known positives: 20-24 2018 269
PMTCT_STAT By Number of known positives: 25-49 2018 511
PMTCT_STAT By Number of known positives: Unknown Age 2018 1,599
PMTCT_STAT By Number of new negative: 15-19 2018 4,245
PMTCT_STAT By Number of new negative: 20-24 2018 9,798
PMTCT_STAT By Number of new negative: 25-49 2018 18,635
PMTCT_STAT By Number of new negative: Unknown Age 2018 62,597
PMTCT_STAT By Number of new positives: 15-19 2018 189
PMTCT_STAT By Number of new positives: 20-24 2018 440
PMTCT_STAT By Number of new positives: 25-49 2018 835
PMTCT_STAT By Number of new positives: Unknown Age 2018 1,378
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2018 88,437
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2018 100,613
PMTCT_STAT_den By Age (Denominator): <15-19 2018 4,755
PMTCT_STAT_den By Age (Denominator): 15-19 2018 7,257
PMTCT_STAT_den By Age (Denominator): 20-24 2018 16,774
PMTCT_STAT_den By Age (Denominator): 20-24 2018 10,981
PMTCT_STAT_den By Age (Denominator): 25-49 2018 31,841
PMTCT_STAT_den By Age (Denominator): 25-49 2018 20,845
PMTCT_STAT_den By Age (Denominator): Unknown Age 2018 37,526
PMTCT_STAT_den By Age (Denominator): Unknown Age 2018 69,021
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 61
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 133
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 530
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 1,390
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 66
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 160
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 400
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 1,092
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2018 1,057
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2018 2,775
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2018 1,057
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2018 2,775
TB_ART_den Aggregated Age/Sex: Female <15 (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 61
TB_ART_den Aggregated Age/Sex: Female <15 (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 133
TB_ART_den Aggregated Age/Sex: Female 15+ (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 530
TB_ART_den Aggregated Age/Sex: Female 15+ (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 1,328
TB_ART_den Aggregated Age/Sex: Male <15 (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 66
TB_ART_den Aggregated Age/Sex: Male <15 (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 160
TB_ART_den Aggregated Age/Sex: Male 15+ (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 400
TB_ART_den Aggregated Age/Sex: Male 15+ (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 1,151
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 446
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 898
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 1,051
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 2,781
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 533
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 995
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 758
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 2,612
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2018 2,788
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2018 7,286
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2018 3,001
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2018 7,669
TB_STAT_den Aggregated Age/Sex: Female <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 467
TB_STAT_den Aggregated Age/Sex: Female <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 947
TB_STAT_den Aggregated Age/Sex: Female 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 1,143
TB_STAT_den Aggregated Age/Sex: Female 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 2,928
TB_STAT_den Aggregated Age/Sex: Male <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 552
TB_STAT_den Aggregated Age/Sex: Male <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 1,045
TB_STAT_den Aggregated Age/Sex: Male 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 839
TB_STAT_den Aggregated Age/Sex: Male 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 2,749
TX_CURR Aggregated Age/Sex: <15 Female 2018 413
TX_CURR Aggregated Age/Sex: <15 Female 2018 3,418
TX_CURR Aggregated Age/Sex: <15 Male 2018 317
TX_CURR Aggregated Age/Sex: <15 Male 2018 2,602
TX_CURR Aggregated Age/Sex: 15+ Female 2018 22,699
TX_CURR Aggregated Age/Sex: 15+ Female 2018 47,831
TX_CURR Aggregated Age/Sex: 15+ Male 2018 14,805
TX_CURR Aggregated Age/Sex: 15+ Male 2018 40,547
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2018 38,234
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2018 94,398
TX_CURR Sum of Aggregated Age/Sex <15 2018 730
TX_CURR Sum of Aggregated Age/Sex <15 2018 6,020
TX_CURR Sum of Aggregated Age/Sex 15+ 2018 37,504
TX_CURR Sum of Aggregated Age/Sex 15+ 2018 88,378
TX_CURR Sum of Aggregated Age/Sex disaggregates 2018 38,234
TX_CURR Sum of Aggregated Age/Sex disaggregates 2018 94,398
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2018 91
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2018 364
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2018 52
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2018 242
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2018 10,190
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2018 7,862
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2018 6,367
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2018 7,361
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2018 16,700
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2018 15,829
TX_NEW Sum of Aggregated Age/Sex disaggregates 2018 16,700
TX_NEW Sum of Aggregated Age/Sex disaggregates 2018 15,829
TX_PVLS <15, Undocumented Test Indication, Female 2018 2
TX_PVLS <15, Undocumented Test Indication, Female 2018 6
TX_PVLS <15, Undocumented Test Indication, Male 2018 2
TX_PVLS <15, Undocumented Test Indication, Male 2018 6
TX_PVLS 15+, Undocumented Test Indication, Female 2018 59
TX_PVLS 15+, Undocumented Test Indication, Female 2018 111
TX_PVLS 15+, Undocumented Test Indication, Male 2018 41
TX_PVLS 15+, Undocumented Test Indication, Male 2018 99
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2018 1,008
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2018 19,098
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2018 892
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2018 17,008
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Female Routine 2018 9
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Female Routine 2018 346
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Female Targeted 2018 81
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Male Routine 2018 21
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Male Routine 2018 461
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Male Targeted 2018 1
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Male Targeted 2018 68
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 528
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 8,107
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Female Targeted 2018 20
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Female Targeted 2018 1,248
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 300
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 5,723
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Male Targeted 2018 13
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Male Targeted 2018 868
TX_PVLS Numerator: Indication: Routine 2018 857
TX_PVLS Numerator: Indication: Routine 2018 14,637
TX_PVLS Numerator: Indication: Targeted 2018 35
TX_PVLS Numerator: Indication: Targeted 2018 2,267
TX_PVLS Numerator: Preg/BF by Indication: Pregnant Routine 2018 4
TX_PVLS Undocumented Test Indication 2018 104
TX_PVLS Undocumented Test Indication 2018 220
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Routine 2018 10
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Routine 2018 456
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Targeted 2018 78
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Male Routine 2018 22
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Male Routine 2018 508
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Male Targeted 2018 1
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Male Targeted 2018 73
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 596
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 8,282
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Targeted 2018 32
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Targeted 2018 1,191
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 333
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 7,004
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Targeted 2018 14
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Targeted 2018 1,047
TX_PVLS_den Denominator: Indication: Routine 2018 951
TX_PVLS_den Denominator: Indication: Routine 2018 16,276
TX_PVLS_den Denominator: Indication: Targeted 2018 47
TX_PVLS_den Denominator: Indication: Targeted 2018 2,397
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 148
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 296
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 134
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 370
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 9,440
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 7,100
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 5,529
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 6,226
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2018 15,252
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2018 13,992
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2018 16,951
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2018 15,556
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 307
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 130
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 103
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 349
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 7,872
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 10,500
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 7,028
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 6,218
TX_TB Number of ART patients who were screened for TB at least once during the reporting period 2018 12,483
TX_TB Number of ART patients who were screened for TB at least once during the reporting period 2018 74,563
TX_TB Number of ART patients who were started on TB treatment during the reporting period 2018 252
TX_TB Number of ART patients who were started on TB treatment during the reporting period 2018 1,495
TX_TB Numerator: By Aggregated Age/Sex: <15, Female 2018 44
TX_TB Numerator: By Aggregated Age/Sex: <15, Male 2018 55
TX_TB Numerator: By Aggregated Age/Sex: 15+, Female 2018 155
TX_TB Numerator: By Aggregated Age/Sex: 15+, Female 2018 808
TX_TB Numerator: By Aggregated Age/Sex: 15+, Male 2018 96
TX_TB Numerator: By Aggregated Age/Sex: 15+, Male 2018 588
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Female 2018 359
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Female 2018 2,945
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Male 2018 154
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Male 2018 1,958
TX_TB_den Denominator: By Aggregated Age/Sex: 15+, Female 2018 8,381
TX_TB_den Denominator: By Aggregated Age/Sex: 15+, Male 2018 3,589
TX_TB_den Denominator: By Aggregated Age/Sex:15+, Female 2018 41,360
TX_TB_den Denominator: By Aggregated Age/Sex:15+, Male 2018 28,299
Cross Cutting Budget Categories and Known Amounts Total: $292,000
Gender: Gender Based Violence (GBV) $10,000
Post GBV Care
Human Resources for Health $100,000
Water $82,000
Motor Vehicles: Purchased $100,000